Metastatic triple-negative breast cancer successfully treated with bicalutamide

Triple-negative breast cancer (TNBC) is considered the group with the worst prognosis among the four molecular subtypes of breast cancer. The current treatment of metastatic TNBC is traditionally limited to chemotherapy. Androgenic receptors (AR) are an emerging target with therapeutic potential in...

Full description

Bibliographic Details
Main Authors: Salazar Mejía, Carlos Eduardo, García Gutierrez, María Elena, Rodríguez Alvarez, Carlos Javier, Flores Caballero, Miguel Angel, Wimer Castillo, Blanca Otilia, Vidal Gutiérrez, Oscar
Format: Article
Language:English
Published: African Field Epidemiology Network 2020
Online Access:http://eprints.uanl.mx/29984/7/29984.pdf

Similar Items